Table 2. Correlations between the expression of GRAMD1C and clinicopathological characteristics in KIRC.
| Characteristic | n | Low or no expression | High expression | Pearson χ2 | P |
|---|---|---|---|---|---|
| Total | 462 | 231(50.00) | 231(50.00) | ||
| Gender | 13.806 | <0.001* | |||
| Male | 302 | 170(56.30) | 132(43.70) | ||
| Female | 160 | 61(38. 10) | 99(61.90) | ||
| Age | 4.191 | 0.041* | |||
| ≤60 | 230 | 104(45.20) | 126(54.80) | ||
| >60 | 232 | 127(54.70) | 105(45.30) | ||
| Histologic grade | 33.168 | <0.001* | |||
| I& II | 203 | 84(41.40) | 119(58.60) | ||
| III | 190 | 91(47.90) | 99(52.10) | ||
| IV | 69 | 56(81.20) | 13(18.80) | ||
| Clinical stage | 16.064 | 0.001* | |||
| I | 221 | 91(41.20) | 130(58.80) | ||
| II | 49 | 24(49.00) | 25(51.00) | ||
| III | 116 | 67(57.80) | 49(42.20) | ||
| IV | 76 | 49(64.50) | 27(35.50) | ||
| Stage T | 13.098 | 0.001* | |||
| I | 227 | 95(41.90) | 13258.10) | ||
| II | 60 | 31(51.70) | 29(48.30) | ||
| III &IV | 175 | 105(60.00) | 70(40.00) | ||
| Stage M | 7.175 | 0.007* | |||
| 0 | 389 | 184(47.30) | 205(52.70) | ||
| I | 73 | 47(64.40) | 26(35.60) |
Notes.
*
p < 0.05.